| Drug Type Small molecule drug | 
| Synonyms- | 
| Action modulators, blockers, inhibitors | 
| Mechanism Ion channels modulators, Kv1.3 blockers(Voltage-gated potassium channel subunit Kv1.3 blockers), ORAI1 inhibitors(Calcium release-activated calcium channel protein 1 inhibitors) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhasePendingDiscovery | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Autoimmune Diseases | Discovery | United Kingdom  | - | |
| Autoimmune Diseases | Discovery | United Kingdom  | - | |
| Cardiac Conduction System Disease | Discovery | United Kingdom  | - | 





